Pancreatic cancer remains one of the most formidable oncological challenges of our time. Known for its late detection and ...

An expert discusses how treatment selection in blastic plasmacytoid dendritic cell neoplasm (BPDCN) involves balancing ...

An expert discusses how effective blastic plasmacytoid dendritic cell neoplasm (BPDCN) management requires early central ...

Let us delve into some of the TLR agonists in the clinic and why the careful selection of these drugs is crucial.

Sancho’s work highlights a key limitation in the current field of cancer treatment: dendritic cells can often be overlooked when developing immunotherapies. Overall, this work could improve long-term ...

DelveInsight’s Renal Cell Carcinoma Pipeline report depicts a robust space with 30+ active players working to develop 30+ ...

In contrast, this dendritic cell-based immunotherapy aims to induce ... In other words, the treatment helps prevent relapse in the mouse models. Further studies will be needed to assess the ...

First-line treatment with a Keytruda combo had an overall survival of 17.6 months in some with recurrent/metastatic head and ...

A new study from researchers at Moffitt Cancer Center shows that blocking a chemical process called nitrosylation could make ...

Traditionally, viruses have been thought of as a burden that cause disease. Now, viruses are being harnessed to tackle ...